RCKT- Rocket Pharmaceuticals, Inc.

Name: Rocket Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Rocket Pharmaceuticals, Inc. (RCKT) has 19 insiders with recent SEC Form 4 filings, including 2 buys and 11 sells. RCKT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Rtw Investments, LP	19.19M	$70.52M	-
CEO	Shah Gaurav	778.3K	$2.86M	-
COO	Stevens Christopher James	554.1K	$2.04M	-
Other	Patel Kinnari	441.9K	$1.62M	-
Dir	Makker Gotham	395.9K	$1.45M	-

Activity

Buys and sells only

Transactions

10 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 16, 2025	Patel Kinnari67	See Remarks	Sell	1,409	$6.53	$9,197.95	-0.3%	-53.4%	-
May 16, 2025	Schwartz Jonathan David70	See Remarks	Sell	1,582	$6.53	$10,327.30	-0.7%	-53.4%	-
May 16, 2025	Shah Gaurav69	CEO	Sell	3,621	$6.53	$23,637.89	-0.5%	-53.4%	-
May 16, 2025	Wilson Martin86	General Counsel	Sell	946	$6.53	$6,175.49	-0.6%	-53.4%	-
Apr 22, 2025	Militello John71	See Remarks	Sell	718	$7.16	$5,139.44	-1.1%	-55.1%	-
Apr 10, 2025	Shah Gaurav69	CEO	Buy	20,000	$5.08	$101,600.00	+2.6%	-35.2%	-29.4%
Apr 9, 2025	Patel Kinnari67	See Remarks	Buy	21,099	$4.70	$99,165.30	+371.8%	-45.2%	-33.3%
Apr 4, 2025	Ondrey Aaron	Chief Financial Officer	Sell	7,489	$5.29	$39,646.77	-5.5%	-43.4%	-32.4%
Feb 25, 2025	Schwartz Jonathan David70	See Remarks	Sell	15,093	$14.84	$223,965.31	-2.0%	-75.1%	-53.7%
Feb 21, 2025	Patel Kinnari67	See Remarks	Sell	6,078	$10.58	$64,305.24	-1.4%	-37.3%	-63.9%

← PrevPage 3Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC